Absolutely, I often wonder the same.
It’s certainly not the price action that’s keeping people from posting as anyone can see it has a spectacular chart.
It’s successfully going into new territory to treat Cancer and Idiopathic Pulmonary Fibrosis and it’s been awarded two FDA approvals.
It’s peers are in the 400m $us market cap .... AMP945 is proving to be more successful than its competitors.
I see this as one hell of an opportunity ...
.
Ann: Amplia Initiates Multiple Dose Study of AMP945, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $30.22M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.0¢ | $15.65K | 148.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 95688 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 28899 | 1 |
View Market Depth
| Last trade - 15.51pm 13/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |